Scientific Program As of January 3, Wednesday, 20 February 2019 HALL A7 A2 A3 M1 14:30-16:00

Similar documents
Preliminary Scientific Program As of January 1, Wednesday, 20 February 2019 HALL A7 A2 A3 M1 14:30-16:00

Preliminary Scientific Program As of December 16, Wednesday, 20 February 2019 PARALLEL INDUSTRY SYMPOSIUM 16:15-17:45 18:00-19:00

Preliminary Scientific Program As of October 25, Wednesday, 20 February 2019 SYMPOSIUM 16:15-17:45

PRELIMINARY SCIENTIFIC PROGRAM As of 29 January Wednesday, 14 February 2018 HALL HALL B HALL L3 HALL M HALL N 14:30-16:00

PRELIMINARY SCIENTIFIC PROGRAM As of December 28, :30-16:00 PARALLEL INDUSTRY WORKSHOP PARALLEL INDUSTRY WORKSHOP PARALLEL INDUSTRY WORKSHOP

SCIENTIFIC PROGRAM. PARALLEL INDUSTRY WORKSHOP Industry session not included in main event PARALLEL INDUSTRY WORKSHOP

PRACTICAL WAYS TO ACHIEVE TARGETS IN DIABETES CARE July 12-15, 2012 Keystone, Colorado

JDRF Perspective on Closed Loop

CONFERENCE SCHEDULE. Wednesday, July 11, Thursday, July 12, PLENARY ONE: Glucose Control, Lipids, and CVD Chair: Marian Rewers, MD, PhD

JDRF RESEARCH UPDATE. Daniel Finan, Ph.D. Research Director

The artificial pancreas: the next step in connectivity and digital treatment of type 1 diabetes

Future Direction of Artificial Pancreas. Roy W. Beck, MD, PhD. JAEB Center for Health Research Tampa, Florida

What is a CGM? (Continuous Glucose Monitor) The Bionic Pancreas Is Coming

Reduction in Hypoglycemia and No Increase in A1C with Threshold-Based Sensor-Augmented Pump (SAP) Insulin Suspension: ASPIRE In-Home

PREVENTION OF NOCTURNAL HYPOGLYCEMIA USING PREDICTIVE LOW GLUCOSE SUSPEND (PLGS)

CAROLINAS CHAPTER/AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS Annual Meeting HILTON HEAD ISLAND FRIDAY PRESENTATION

More Than 1 Year of Hybrid Closed Loop in Pediatrics. Gregory P. Forlenza, MD Assistant Professor Barbara Davis Center

Artificial Pancreas Device System (APDS)

When Will CGM Replace SMBG? Roy W. Beck, MD, PhD. JAEB Center for Health Research Tampa, Florida

Diabetes Management: Current High Tech Innovations

What is the role of insulin pumps in the modern day care of patients with Type 1 diabetes?

NEWS BRIEFING Advances in Technology. moderated by: Irl Hirsch, MD University of Washington Medical Center

DIABETES TECHNOLOGY: WHERE ARE WE NOW AND WHERE ARE WE GOING? Presented by: Tom Brobson

MEDTRONIC SCIENTIFIC PROGRAM

Insulin Pumps and Glucose Sensors in Diabetes Management

People with type 1 diabetes and Do It Yourself (DIY) technology solutions ABOUT THIS POSITION STATEMENT

Diabetes Management with Continuous Glucose Monitoring & Multiple Daily Injections. Aaron Michels MD

Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes

Technology in Diabetes Management Irl B. Hirsch, MD University of Washington

Paolo Di Bartolo U.O di Diabetologia Dip. Malattie Digestive & Metaboliche AULS Prov. di Ravenna. Ipoglicemie e Monitoraggio Glicemico

Sensor-augmented pump systems provide insulin delivery

Emerging Automated Insulin Delivery Systems

The Realities of Technology in Type 1 Diabetes

CGM and Closing The Loop

How I use the latest technology to investigate and treat a person with Type 1 Diabetes. Dr Pratik Choudhary

The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters

Hypoglycemia a barrier to normoglycemia Are long acting analogues and pumps the answer to the barrier??

Continuous Glucose Monitoring (CGM)

Artificial Pancreas Technologies: New Tools to Improve Diabetes Care Today and Tomorrow

QUESTION 4. WHAT CLINICAL DATA ARE CURRENTLY AVAILABLE TO SUPPORT EXPANDED CGM COVERAGE BY PAYERS AS PERTAINS TO QUESTIONS 1 AND 3?

Clinical News and Innovation in Type 1 Diabetes and Technology. Parth Narendran University Hospitals Birmingham

Artificial Pancreas Device Systems. Populations Interventions Comparators Outcomes. pump. pump

Artificial Pancreas Device Systems. Populations Interventions Comparators Outcomes Individuals: With type 1 diabetes

Presented by Dr. Bruce Perkins, MD MPH Dr. Michael Riddell, PhD

Exercise Prescription in Type 1 Diabetes

Advances in Managing Diabetes in Youth. March 1, 2012

Advances in Technology in the Treatment of Diabetes Mellitus 2017 How far have we come-how far are we going? Is there a final frontier?

The Plan for a World without T1D

The Digital Clinic: Unlock the Power of Diabetes Data Eran Atlas - CEO Copyright DreaMed Diabetes, Ltd. 2017, All Rights Reserved

Advances in Diabetes Care Technologies

Norbert Hermanns, PhD 1,2, Beatrix Schumann, MD 2, Bernhard Kulzer, PhD 1,2, and Thomas Haak, MD 1,2. Original Article

Clinical Evidence for Insulin Pump Therapy

Psychological Reactions Associated With Continuous Glucose Monitoring in Youth

Control of Glycemic Variability for Reducing Hypoglycemia Jae Hyeon Kim

Immunology/ Transplantation. Epidemiology/ Genetics. Mini-Symposium The Future Face of Diabetes Care Beta- Cell Replacement vs. Technology Room: 24

WEDNESDAY, Jun 12. PRECONFERENCE WORKSHOP All Health Professionals 1:00-3:00pm LOWER LIMB ASSESSMENT

Diabetes Technology Continuous Subcutaneous Insulin Infusion Therapy And Continuous Glucose Monitoring In Adults: An Endocrine Society Clinical

Artificial Pancreas Goes Outpatient: A New Diabetes Ecosystem

DIAGNOSIS OF DIABETES NOW WHAT?

Subject Index. Breastfeeding, self-monitoring of blood glucose 56

Insulin Pump Therapy in children. Prof. Abdulmoein Al-Agha, FRCPCH(UK)

HEALTH PROFESSIONALS DAY Thursday, June 13, 2019: OFFICIAL START OF CONFERENCE

Information Overload! CGM, Navigating for Success. Presented by: Kathi Milton RD, CDE and Amy Foreman RN, CDE

FRIDAY, JUNE 21. Epidemiology/ Genetics. Symposium The Big Picture Genetic Architecture of Diabetes Room S 103 B

The next five years in diabetes technology: closed-loop systems

Who has responsibility for emerging technologies in diabetes management

Advances Towards the Bionic Pancreas.

Artificial Pancreas, shortly close to home? BC Pediatric Diabetes Day, Feb 26, 2016

Insulin Delivery and Glucose Monitoring Methods for Diabetes Mellitus: Comparative Effectiveness

Wednesday, July 15, 2015

Science Behind Insulin Delivery

Diabetes Management Continuous Glucose Monitoring

Update on Diabetes Technology

SCIENTIFIC TIMETABLE SIOP 2015

Pump and Sensor Data Interpretation. Irl B. Hirsch, MD University of Washington School of Medicine

Original Article. Nicholas B. Argento, MD 1 ; Katherine Nakamura, PhD 2 ABSTRACT

Clinical Value and Evidence of Continuous Glucose Monitoring

Diabetes Technology in Irl B. Hirsch, MD University of Washington School of Medicine Seattle, WA

Counting the Carbs, Fat and Protein in Type 1 Diabetes Translating the Research into Clinical Practice

Advances in Diabetes Care Technologies

Diabetes Technology Update. Sarah Konigsberg, MD Diabetes & Endocrine Assoc. April 7, 2018

The In-Clinic Close Loop Experience in the US

Inpatient Studies of a Kalman-Filter-Based Predictive Pump Shutoff Algorithm

Continuous Glucose Monitoring (CGM)

Why (and how) I built an artificial

The Hypoglycaemia-Hyperglycaemia Minimizer System in the Management of Type 1 Diabetes. Brian L Levy, Thomas W McCann, Jr and Daniel A Finan

Interpretation of Continuous Glucose Monitoring (CGM) Data

BREAKS NETWORKING EVENTS PARALLEL SESSIONS INDUSTRY SUPPORTED SESSIONS Academy of Autoimmunity SYMPOSIUM

The Diamond Study: Continuous Glucose Monitoring In Patients on Mulitple Daily Insulin Injections

2017 RESEARCH UPDATE A Year of Scientific Progress

8/7/2017 ABOUT JDRF VISION MISSION. No conflicts of interest

Supplementary Appendix

Diabetes Care 32: , for achieving euglycemia in type 1 diabetes

INDUSTRY SUPPORTED SESSIONS. Auditorium I Auditorium II Auditorium VIII Auditorium III Pavilion 3A Pavilion 3B. Academy of Autoimmunity

Preliminary Program Outline

UvA-DARE (Digital Academic Repository) The artificial pancreas Kropff, J. Link to publication

Transcription:

Scientific Program As of January 3, 2019 Plenary Session Parallel Session Oral Presentation Session Industry Session Break Wednesday, 20 February 2019 A7 A2 A3 M1 14:30-16:00 WORKSHOP INDUSTRY SESSION NOT INCLUDED IN MAIN EVENT CME/CPD CREDIT SYMPOSIUM INDUSTRY SESSION NOT INCLUDED IN MAIN EVENT CME/CPD CREDIT WORKSHOP INDUSTRY SESSION NOT INCLUDED IN MAIN EVENT CME/CPD CREDIT 16:15-17:45 18:00-19:00 WORKSHOP INDUSTRY SESSION NOT INCLUDED IN MAIN EVENT CME/CPD CREDIT OPENING CEREMONY Tadej Battelino - Opening Remarks WORKSHOP INDUSTRY SESSION NOT INCLUDED IN MAIN EVENT CME/CPD CREDIT A7 Lutz Heinemann Future of Diabetes Technology where are we going from here? 19:00-20:00 NETWORKING RECEPTION (In the Exhibition Area)

Thursday, 21 February 2019 A7 08:30-10:00 PLENARY SESSION: DECISION SUPPORT SYSTEMS (DSS) Rich Bergenstal- Do we need diabetes decision support systems? Bruce Bode - Use of Decision Support System in the Hospital Moshe Phillip - Advice4U Decision Support Systems for healthcare professionals 10:00-10:30 10:30-12:00 Courtney Lias Regulatory aspects of the use of Decision Support Systems COFFEE BREAK, EXHIBITION, POSTERS AND E-POSTERS DISCUSSIONS 1-3 E-POSTER DISCUSSION 1 AT STATION 2 E-POSTER DISCUSSION 2 AT STATION 4 E-POSTER DISCUSSION 3 AT STATION 6 PLENARY INDUSTRY SYMPOSIUM INDUSTRY SESSION NOT INCLUDED IN MAIN EVENT CME/CPD CREDIT 12:00- LUNCH BREAK, EXHIBITION, E-POSTERS AND POSTERS, INTERNATIONAL FAIR OF NEW TECHNOLOGIES IN DIABETES 13:00 A1 A8 A2 A5 A3 M4 13:00-14:30 NEW AVENUES IN PROTEIN DRUGS FOR DIABETES TIME IN RANGES (TIRs) NUTRITION AND FOOD TECHNOLOGY JDRF PARALLEL SESSION: TOWARD NEXT- GENERATION PHYSIOLOGIC AUTOMATED INSULIN DELIVERY (AID) SYSTEMS: A PROMISING FRONTIER PARALLEL INDUSTRY SYMPOSIUM INDUSTRY SESSION NOT INCLUDED IN MAIN EVENT CME/CPD CREDIT PARALLEL INDUSRY WORKSHOP INDUSTRY SESSION NOT INCLUDED IN MAIN EVENT CME/CPD CREDIT

Cliff Bailey - Targeting more than one receptor Melanie Davies - Oral absorption of protein drugs Tim Heise - Smart insulins Jessica Castle - Stable Glucagon Simon Heller - Exploring and explaining the rational for a new and extending classification of hypoglycemia in an era of CGM Roy Beck - Time in Range as an outcome in clinical trials Irl Hirsch Time in Range(s) vs. HbA1c: Are Our Patients Ready to Change? Tadej Battelino Time in Range towards a consensus Ram Weiss - personalized nutrition: the time has come? Michal Gillon - Complementary sensors technologies for food consumption monitoring Andrea Scaramuzza - Efficacy of an app to count carbs to limit the post-meal glucose rise in children with type 1 diabetes Jaime Giraldo - JDRF Strategy and Perspective Eric Renard - Current Status of Physiologic Insulin Delivery: Clinical Benefits and Challenges Eyal Dassau - Algorithms for Automated Delivery of Insulin in the Intraperitoneal (IP) Space Guillermo Arreaza- Rubin - Implantable IP AID Systems: Assessment of Needs Jackie Le Grand - Opportunities and Challenges in Adoption of and Access to Implantable IP AID Systems Moderated Panel Q&A Moderator - Daniel Finan Panel - Eric Renard, Eyal Dassau, Guillermo Arreaza-Rubin, Katharine Barnard,

Anne Nordyke, Greg Peterson 14:30-15:00 COFFEE BREAK, EXHIBITION, E-POSTERS AND POSTERS, INTERNATIONAL FAIR OF NEW TECHNOLOGIES IN DIABETES A8 15:00-16:30 PLENARY INDUSTRY SYMPOSIUM INDUSTRY SESSION NOT INCLUDED IN MAIN EVENT CME/CPD CREDIT A3 A1 A8 M1 M4 16:40-18:00 COGNITION IN DIABETES NOVEL BIOMARKERS FOR DIABETES CLOSED-LOOP SYSTEMS WHERE ARE WE NOW? SESSION 1 SESSION 2 Pratik Choudhary Impact of hypoglycemia on cognitive function Jasna Šuput Omladič Impact of Hyperglycemia on cognitive function Stuart Weinzimer - Brain and cognitive consequences of type 1 diabetes (T1D) the DirecNet Project Stephanie Amiel - Hypo in clinical trials and viceversa Lorena Wright - Novel Diabetes Biomarkers: An Update of 1,5 AG for the Clinician Marcello Ciaccio - Glycated Albumin: from biochemistry to clinical applications Markus Stoffel- noncodingrna in Diabetes Desmond Schatz Novel Biomarkers identified by international prevention-studies Bruce Bode - Outcomes of the Medtronic 670G in diabetes clinics in the USA Roman Hovorka Progress on using Cambridge Closed-Loop algorithm Eyal Dassau Harvard's experience with closed-loop Sue Brown Virginia's experience with closed-loop Tadej Battelino update from the FLAIR study Ahmad Haidar Pramlintide in the artificial pancreas John Pickup - values vs. affordability of diabetes technology

09:00-10:00 NEW MODELS OF IMPLEMENTING CGM Friday, 22 February 2019 A1 A8 A3 A2 M4 ADJUNCTIVE THERAPIES FOR T1D PSYCHOLOGICAL INTERVENTION TO INCREASE THE USE OF TECHNOLOGY BY T1D PATIENTS SESSION 3 SYMPOSIUM INDUSTRY SESSION NOT INCLUDED IN MAIN EVENT CME/CPD CREDIT Tom Martens CGM use in a primary care network Amit Majithia - CGM for type 2 diabetes direct to consumer Roy Beck CGM use for type 1 diabetes direct to consumer Satish Garg Emerging role of Adjunctive Therapies for T1D Chantal Mathieu - The concept of SGLT in diabetes Thomas Danne - Report on the consensus on SGLT in T1D Alon Liberman - Introduction Susana R. Patton - Adherence to Insulin Pump Behaviors in Young Children with Type 1 Diabetes Mellitus: Opportunities for Intervention Katharine Barnard - Psychosocial Aspects & Diabetes Technology- Head to Head or Hand in Hand? Korey Hood - Preventing poor psychosocial and glycemic outcomes in teens with type 1 diabetes 10:00-10:30 COFFEE BREAK, EXHIBITION, POSTERS AND E-POSTERS DISCUSSIONS 4-6 E-POSTER DISCUSSION 4 AT STATION 2 E-POSTER DISCUSSION 5 AT STATION 4 E-POSTER DISCUSSION 6 AT STATION 6 A7 10:30-12:00 PLENARY INDUSTRY SYMPOSIUM INDUSTRY SESSION NOT INCLUDED IN MAIN EVENT CME/CPD CREDIT

12:00-13:00 LUNCH BREAK, EXHIBITION, E-POSTERS AND POSTERS, INTERNATIONAL FAIR OF NEW TECHNOLOGIES IN DIABETES 13:00-14:30 PLENARY SESSION: ATTD YEARBOOK Satish Garg -Self-monitoring of Blood Glucose Satish Garg - New Medications for the Treatment of Diabetes Bruce Bode/Tadej Battelino - Continuous Glucose Monitoring John Pickup - Insulin Pumps Eyal Dassau/Revital Nimri Decision Support System and Closed-Loop Lutz Heinemann - New Insulins, biosimilars, and Insulin Therapy Desmond Schatz - Immune Intervention for type 1 diabetes Helen Murphy - Technology and Pregnancy Michael C. Riddell - Advances in Exercise, Physical Activity and Diabetes Mellitus David Maahs - Diabetes Technology and Therapy in the Pediatric Age Group Alon Liberman - Diabetes Technology and the Human Factor Laurel Messer - Practical Implementation of Diabetes Technology: It is Time 14:30-15:00 COFFEE BREAK, EXHIBITION, POSTERS AND E-POSTERS 15:00-16:30 PLENARY INDUSTRY SYMPOSIUM INDUSTRY SESSION NOT INCLUDED IN MAIN EVENT CME/CPD CREDIT A8 A1 A3 A2 M1 16:40-18:10 PATIENT DECISION SUPPORT: CONCEPT AND TOOLS PATIENT-REPORTED OUTCOME MEASURES (PROMS) AND OUTCOME DRIVEN MEDICINE DIABETES EDUCATION WORKSHOP INDUSTRY SESSION NOT INCLUDED IN MAIN EVENT CME/CPD CREDIT SYMPOSIUM INDUSTRY SESSION NOT INCLUDED IN MAIN EVENT CME/CPD CREDIT

Boris Kovatchev - Decision support system for patients with diabetes: concept, goals and feasibility Pau Herrero - A better care for diabetes Lutz Heinemann - Integrated Personalized Diabetes Management: Results of the Pro Value Studies Revital Nimri - Decision Support Systems directly to the patients Katharine Barnard - Evaluation of Patient- Reported Outcome Measures (PROMs). Michael Riddell PROMs, Apps and Exercise in Diabetes Mark Palmert - A Mobile App for the Self- Management of Type 1 Diabetes Among Adolescents: A Randomized Controlled Trial Andrea Scaramuzza - Education in Predictive Low Glucose Management (PLGM) Debate: What is more important: Lori Laffel - Structured education Hood Thabit: Diabetes Technology (closed-loop) Laurel Messer - The importance of education in Closed-loop Goran Petrovski - Education through Facebook and other social media

Saturday, 23 February 2019 A3 A1 A2 M1 M4 08:30-10:00 THERAPIES IN TYPE 2 DIABETES WHAT PATIENTS DO WITH CGM DATA AND WHAT THEY SHOULD DO DATA DIABETES SCIENCE SESSION 4 SESSION 5 Richard Bergenstal Does MDI therapy really work in T2D Nebojsa Lalic - Pumps in T2D Jane Reusch - Add on to basal insulin: patient centered considerations Oliver Schnell - The role of HbA1c point of care testing in the management of diabetes and cardiovascular disease Norbert Hermanns - Medical Need for training courses for patients to make optimal usage of CGM (rtcgm and isccgm) Hans DeVries - CGM for hypoglycemia-prone patients Gérard Reach - Decisions in the psychology of glucose monitoring Francis Doyle - Adaptive Automated Control of Diabetes the Ultimate Personalized Diabetes Treatment Howard Zisser - The Connected Patient Boris Kovatchev - Building a virtual image of patient the VIP approach to precision medicine for diabetes Discussion 10:00-10:30 COFFEE BREAK, EXHIBITION, POSTERS AND E-POSTERS

A3 A1 A2 M1 10:30-11:30 ULTRA RAPID ACTING INSULINS AND TECHNOLOGY ISPAD DIABETES TECHNOLOGY IN PEDIATRICS: ISPAD GUIDELINES UPDATE AND THE FUTURE DO IT YOURSELF IN DIABETES SESSION 6 David Klonoff Rapid Acting Insulin in CSII Bruce Bode - Ultra Rapid acting insulin in Closed-Loop systems Klemen Dovc Rapid Acting Insulin, exercise and Closed-Loop Jennifer Sherr - Insulin pumps Martin de Bock - Continuous glucose monitoring Martin Tauschmann - Sensor augmented pump, hybrid closed loop, closed-loop Aaron Kowalski Interoperable and Do-It-Yourself systems Lenka Petruzelkova - The European perspective of DIY for Closed-Loop Dana Lewis "#WeAreNotWaiting: DIY Diabetes Data & Research 11:30-12:30 PLENARY SESSION: BETA CELL REPLACEMENT STRATEGIES 2019 A1 Pratik Chaudhary - Future of Islet transplantation, latest outcomes and who should be referred Lorenzo Piemonti Future Landscape: Defining a successful outcome using stem cells as a source of insulin producing cells Jay Skyler - Beta cell replacement 2019 and beyond 12:30-13:00 PLENARY SESSION: THE LONGTERM FUTURE OF DIABETES CARE Tobias Daniel Gantner - Things are only impossible as long as they are not. How seamless integration will change healthcare for good and the better. Diabetes as a blueprint for digital transformation in healthcare. 13:00-13:35 CLOSING REMARKS AND FAREWELL Moshe Phillip 13:35-14:20 FAREWELL REFRESHMENTS (In the Exhibition Area) A1